EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits with Severe Acute Kidney Injury Successfully Managed by Clone-Directed Therapy: A Case Report

Shohei Maekawa, Shinya Yamamoto, Tatsuaki Kosaka, Hisashi Kamido, Yasuyuki Arai, Yayoi Ogawa, Naoka Murakami, Yuki Teramoto, Motoko Yanagita

Nephron · 18.04.2026 · 1-9

DOI: 10.1159/000552029 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephron, online erschienen am 18.04.2026. Verfasst von Shohei Maekawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Kyoto University Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Acute Kidney Injury, Glomerulonephritis, Membranoproliferative, Glomerulonephritis, Immunoglobulins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a form of monoclonal gammopathy of renal significance, characterized by kidney injury caused by monoclonal immunoglobulin deposition in the glomeruli. While detectable clones are only found in 20–30% of PGNMID, plasma cell- or B-cell-targeting therapies are suggested to be effective. Recent case reports suggested immune dysregulation, such as viral infections or vaccinations, could potentially trigger the onset or relapse of PGNMID. Here, we report a case of PGNMID without detectable clones, which relapsed after viral enteritis, presenting with severe acute kidney injury (AKI) and nephrotic syndrome. Case Presentation: A 60-year-old man, originally diagnosed with IgG3 lambda type PGNMID with nephrotic syndrome (urine protein/creatinine ratio (UPCR) of 5.3 g/gCr), was treated with non-clone-directed therapeutic regimens, including glucocorticoids. The patient initially achieved a partial response with a UPCR of 1–3 g/gCr and negative microhematuria. Approximately 2 years later, the patient presented with severe AKI (Cr 11.0 mg/dL) requiring dialysis, and nephrotic syndrome (UPCR 5.5 g/gCr, and serum albumin 2.4 g/dL) after having had viral enteritis. Second kidney biopsy confirmed a similar pattern of injury consistent with PGNMID with IgG3 lambda deposition, severe endocapillary inflammation, mesangial expansion, and remarkable narrowing of the glomerular capillary lumina. As it was refractory to glucocorticoid pulse therapy, clone-directed therapies with daratumumab and bortezomib were initiated. This intervention resulted in the cessation of dialysis and an improvement in urinary parameters.

Conclusion

Clinicians should recognize that severe AKI may develop during the course of PGNMID, potentially triggered by infections. Furthermore, this case highlights the efficacy of clone-directed therapy with daratumumab and bortezomib in treating recurrent PGNMID without detectable clones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryGlomerulonephritis, MembranoproliferativeGlomerulonephritisImmunoglobulinsHumansMaleMiddle AgedAntibodies, Monoclonal

Stichwörter der Autor:innen

Acute kidney injuryInfectionMonoclonal gammopathy of renal significanceProliferative glomerulonephritis with monoclonal immunoglobulin deposits

Substanzen

Antibodies, MonoclonalImmunoglobulins

Autor:innen und Institutionen

  • Department of Nephrology, Kyoto University Hospital, Kyoto, Japan.
  • Department of Nephrology, Kyoto University Hospital, Kyoto, Japan, syamamon@kuhp.kyoto-u.ac.jp.
  • Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Department of Pathology, Sapporo Tokushukai Hospital, Sapporo, Japan.
  • Division of Nephrology, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

Zitieren

APA

Maekawa, S., Yamamoto, S., Kosaka, T., Kamido, H., Arai, Y., Ogawa, Y., Murakami, N., Teramoto, Y., & Yanagita, M. (2026). Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits with Severe Acute Kidney Injury Successfully Managed by Clone-Directed Therapy: A Case Report. Nephron, 1-9. https://doi.org/10.1159/000552029

Vancouver

Maekawa S, Yamamoto S, Kosaka T, Kamido H, Arai Y, Ogawa Y, et al. Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits with Severe Acute Kidney Injury Successfully Managed by Clone-Directed Therapy: A Case Report. Nephron. 2026:1-9. doi:10.1159/000552029

BibTeX
@article{Maekawa2026,
  author = {Maekawa, Shohei and Yamamoto, Shinya and Kosaka, Tatsuaki and Kamido, Hisashi and Arai, Yasuyuki and Ogawa, Yayoi and Murakami, Naoka and Teramoto, Yuki and Yanagita, Motoko},
  title = {Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits with Severe Acute Kidney Injury Successfully Managed by Clone-Directed Therapy: A Case Report},
  journal = {Nephron},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000552029}
}
Kostenlos starten →